ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,235Medicare Part D Prescriptions Filled, Including Refills

Rank: 28 out of 1269

$876K Total Retail Price of All Prescriptions

Rank: 38 out of 1269

484 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 484 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

6% of this provider’s 484 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 12,999 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
LEVOTHYROXINE SODIUM 554 517 1 4
WARFARIN SODIUM 529 506 2 12
METOPROLOL TARTRATE 450 402 3 6
SIMVASTATIN 388 350 4 3
FUROSEMIDE 382 352 5 5
AMLODIPINE BESYLATE 374 331 6 2
LISINOPRIL 364 310 7 1
OMEPRAZOLE 296 270 8 8
DONEPEZIL HCL 296 295 8 22
MIRTAZAPINE 284 279 10 24
TRAMADOL HCL 283 274 11 16
CITALOPRAM HBR 251 229 12 21
METOPROLOL SUCCINATE 232 219 13 13
SERTRALINE HCL 224 198 14 23
NAMENDA 219 215 15 38
TRAZODONE HCL 205 202 16 36
ATORVASTATIN CALCIUM 202 188 17 7
GABAPENTIN 173 94 18 17
LOSARTAN POTASSIUM 162 161 19 15
ATENOLOL 155 140 20 14
ESCITALOPRAM OXALATE 152 152 21 58
HYDROCHLOROTHIAZIDE 148 137 22 10
CLOPIDOGREL 148 138 22 32
METFORMIN HCL 148 129 22 9
TAMSULOSIN HCL 142 129 25 31
CYMBALTA 138 127 26 70
LIDODERM 134 132 27 56
PANTOPRAZOLE SODIUM 133 127 28 18
POTASSIUM CHLORIDE 132 132 29 26
CARBIDOPA-LEVODOPA 131 122 30 78
HYDROCODONE-ACETAMINOPHEN 122 120 S3 31 20
RISPERIDONE 105 104 32 43
ALLOPURINOL 104 104 33 49
POLYETHYLENE GLYCOL 3350 104 96 33 50
KLOR-CON M20 103 83 35 60
PRAVASTATIN SODIUM 99 81 36 11
ZOLPIDEM TARTRATE 95 78 37 19
QUETIAPINE FUMARATE 89 86 38 53
DIVALPROEX SODIUM 86 85 39 54
LANTUS 85 60 40 39
ALENDRONATE SODIUM 84 58 41 28
CRESTOR 81 81 42 25
DIOVAN 80 80 43 35
HYDRALAZINE HCL 79 62 44 48
PLAVIX 78 76 45 47
CIPROFLOXACIN HCL 77 71 46 66
PAROXETINE HCL 74 74 47 71
FAMOTIDINE 73 71 48 85
OXYBUTYNIN CHLORIDE ER 71 62 49 130
ISOSORBIDE MONONITRATE ER 71 54 49 63
KETOCONAZOLE 70 67 51 203
RENVELA 70 59 51 221
RANITIDINE HCL 65 63 53 27
FLUTICASONE PROPIONATE 65 54 53 40
FLUOXETINE HCL 65 60 53 83
LATANOPROST 62 62 56 143
CARVEDILOL 61 60 57 29
MELOXICAM 61 61 57 68
ADVAIR DISKUS 61 59 57 46
FENOFIBRATE 60 58 60 115
LOVASTATIN 58 58 61 30
GLIPIZIDE 58 55 61 37
EXELON 57 57 63 142
CLONIDINE HCL 56 46 64 51
DIGOXIN 53 53 65 62
DILTIAZEM 24HR CD 53 53 65 146
SULFAMETHOXAZOLE-TRIMETHOPRIM 52 40 67 84
LACTULOSE 52 23 67 67
NYSTOP 51 44 69 186
PREDNISONE 51 47 69 45
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 16, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.